The FDA approved Cleveland Diagnostics' blood-based test to help diagnose high-grade prostate tumors and aid in biopsy decisions, the company announced. Dubbed IsoPSA, the in vitro diagnostic kit is ...
I’m a traditional software engineer. Join me for the first in a series of articles chronicling my hands-on journey into AI ...
A one-week-old 2026 Tesla Model X has left a family reeling after its signature doors "refused to open" during pouring rain, ...
BACKGROUND: Mental stress-induced myocardial ischemia is often clinically silent and associated with increased cardiovascular risk, particularly in women. Conventional ECG-based detection is limited, ...
GRAYLING, MI – A Northern Michigan defense training complex based out of Camp Grayling has been chosen by the federal government to test and train drones. The announcement made this week by the ...
Yann LeCun, Meta’s outgoing chief AI scientist, says his employer tested its latest Llama model in a way that may have made the model look better than it really was. In a recent Financial Times ...
Electrochemical impedance spectroscopy (EIS) provides valuable insights into the physical processes within batteries – but how can these measurements directly inform physics-based models? In this ...
I’m going to go ahead and say it: what happens online doesn’t always necessarily square up with what’s actually going on in real life. Yes, we all know that Elon Musk’s political opinions are ...
The FDA has granted Cleveland Diagnostics’ IsoPSA test premarket approval (PMA) to help detect prostate cancer in men aged 50 years or older with elevated PSA levels. IsoPSA is a blood assay that ...
CLEVELAND--(BUSINESS WIRE)--Cleveland Diagnostics, Inc., a pioneering, commercial-stage precision oncology company, announced today that the U.S. Food and Drug Administration (FDA) has approved the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results